Inspect Filled Ampoules for Visual and Physical Defects Post-Filling

Always Inspect Filled Ampoules for Visual and Physical Defects

Remember: Always perform post-filling inspection of ampoules to detect cracks, seal anomalies, or particulate matter — essential for sterility and GMP compliance.

Why This Matters in GMP

Filled ampoules, commonly used for sterile injectables, are vulnerable to defects such as tip cracks, improper fusion, entrapped particulates, and mislabeling. If these are not detected and removed, they can compromise patient safety, cause serious adverse events, and result in regulatory actions. Visual and physical inspection ensures each ampoule meets specifications for sterility, clarity, and integrity before release.

Also Read: Clean Pass Boxes Before and After Every Transfer in GMP Facilities

For example, an ampoule with a microcrack may not maintain a sterile barrier, potentially leading to microbial ingress and contamination. If particulate matter or glass shards are present due to poor sealing or breakage during filling, it may cause embolism or allergic reactions in patients. Therefore, GMP mandates 100% visual inspection of ampoules using validated methods.

Regulatory and Compliance Implications

21 CFR Part 211.94 requires that containers be clean and properly sealed, and that their integrity be ensured before use. EU GMP Annex 1 mandates inspection of all filled units in sterile manufacturing. WHO GMP reinforces container closure integrity and physical inspection

as part of the batch release process.

Also Read: Update GMP Training Records After Every Training Session

Auditors review inspection procedures, defect classification (critical, major, minor), inspector qualification records, and batch rejection rates. Inadequate or unvalidated inspection processes — especially in high-risk sterile operations — can result in severe audit findings and product withdrawal mandates.

Implementation Best Practices

Use a combination of automated and manual inspection systems validated for detecting critical defects. Define clear acceptance and rejection criteria based on defect type. Train personnel in visual inspection techniques, lighting requirements, and inspection timing. Rotate inspectors to prevent fatigue and subjective bias.

Maintain logs of inspection outcomes, defect trends, and inspector performance metrics. Perform periodic requalification of inspection systems and revalidation of defect detection sensitivity. Include ampoule inspection in line clearance and product disposition protocols.

Also Read: Don’t Place Raw Material Containers in Unclassified Areas Under GMP

Regulatory References

– 21 CFR Part 211.94 – Container and closure integrity
– EU GMP Annex 1 – Sterile manufacturing and visual inspection
– WHO TRS 961, Annex 6 – Inspection of sterile containers
– USP – Visual Inspection of Injections